Van Naarden Jacob 4
4 · ELI LILLY & Co · Filed Feb 4, 2025
Insider Transaction Report
Form 4
Van Naarden Jacob
EVP,Pres LLY Oncology&HdCorpBD
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-02-01−3,023→ 0 totalFrom: 2025-02-01Exp: 2025-02-01→ Common Stock (3,023 underlying) - Exercise/Conversion
Common Stock
2025-02-01+3,023→ 14,868 total - Tax Payment
Common Stock
2025-02-01$811.08/sh−1,409.839$1,143,492→ 13,458.161 total
Holdings
- 4,342(indirect: By Trust)
Common Stock
- 4,302(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.